Release Date: 22/11/13 09:28 Summary: Company Notice - paragraph 633(4)(a) of Corporations Act Price Sensitive: No Download Document 459KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%